tiprankstipranks
Advertisement
Advertisement

ANIP Stock Latest News

ANI Pharmaceuticals announces FDA approval, launch of Pimozide Tablets
The FlyANI Pharmaceuticals announces FDA approval, launch of Pimozide Tablets
11d ago
ANIP
ANI Pharmaceuticals launches Isosorbide Mononitrate Tablet USP
PremiumThe Fly
ANI Pharmaceuticals launches Isosorbide Mononitrate Tablet USP
23d ago
ANIP
ANI Pharmaceuticals announces publication of iluvien clinical trial results
PremiumThe Fly
ANI Pharmaceuticals announces publication of iluvien clinical trial results
24d ago
ANIP
ANI Pharmaceuticals Highlights Updated Non-GAAP Metrics to Investors
PremiumCompany Announcements
ANI Pharmaceuticals Highlights Updated Non-GAAP Metrics to Investors
2M ago
8K
ANIP
ANI Pharmaceuticals Signals Strong Growth in 2025 Call
PremiumCompany Announcements
ANI Pharmaceuticals Signals Strong Growth in 2025 Call
2M ago
ANIP
ANI Pharmaceuticals Posts Record 2025 Results on Rare Disease Growth
PremiumCompany AnnouncementsANI Pharmaceuticals Posts Record 2025 Results on Rare Disease Growth
2M ago
ANIP
ANI Pharmaceuticals reports Q4 adjusted EPS $2.33, consensus $1.98
Premium
The Fly
ANI Pharmaceuticals reports Q4 adjusted EPS $2.33, consensus $1.98
2M ago
ANIP
ANI Pharmaceuticals sees FY26 adjusted EPS $8.83-$9.34, consensus $8.64
Premium
The Fly
ANI Pharmaceuticals sees FY26 adjusted EPS $8.83-$9.34, consensus $8.64
2M ago
ANIP
ANIP Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ANIP Upcoming Earnings Report: What to Expect?
2M ago
ANIP
ANI Pharmaceuticals price target raised to $124 from $115 at Guggenheim
PremiumThe Fly
ANI Pharmaceuticals price target raised to $124 from $115 at Guggenheim
3M ago
ANIP
ANI Pharmaceuticals issues strong 2025 preliminary results, 2026 outlook
PremiumCompany Announcements
ANI Pharmaceuticals issues strong 2025 preliminary results, 2026 outlook
4M ago
8K
ANIP
ANI Pharmaceuticals sees FY26 revenue $1.055B-$1.115B, consensus $955.04M.
PremiumThe Fly
ANI Pharmaceuticals sees FY26 revenue $1.055B-$1.115B, consensus $955.04M.
4M ago
ANIP
ANI Pharmaceuticals sees FY23 EPS, revenue ‘within or above guidance ranges’
PremiumThe FlyANI Pharmaceuticals sees FY23 EPS, revenue ‘within or above guidance ranges’
4M ago
ANIP
ANI Pharmaceuticals Announces Leadership Transition in Board
Premium
Company Announcements
ANI Pharmaceuticals Announces Leadership Transition in Board
5M ago
8K
ANIP
ANI Pharmaceuticals chairman Patrick Walsh to retire, Thomas Haughey to succeed
Premium
The Fly
ANI Pharmaceuticals chairman Patrick Walsh to retire, Thomas Haughey to succeed
5M ago
ANIP
ANI Pharmaceuticals Highlights November 2025 Financial Strategies
PremiumCompany Announcements
ANI Pharmaceuticals Highlights November 2025 Financial Strategies
6M ago
8K
ANIP
ANI Pharmaceuticals price target raised to $115 from $114 at Guggenheim
PremiumThe Fly
ANI Pharmaceuticals price target raised to $115 from $114 at Guggenheim
6M ago
ANIP
ANI Pharmaceuticals’ Earnings Call Highlights Record Growth
PremiumCompany Announcements
ANI Pharmaceuticals’ Earnings Call Highlights Record Growth
6M ago
ANIP
ANI Pharmaceuticals Reports Record Q3 2025 Results
PremiumCompany Announcements
ANI Pharmaceuticals Reports Record Q3 2025 Results
6M ago
ANIP
ANI Pharmaceuticals: Strong Commercial Execution and Promising Growth Prospects Reinforce Buy Rating
PremiumRatingsANI Pharmaceuticals: Strong Commercial Execution and Promising Growth Prospects Reinforce Buy Rating
6M ago
ANIP
ANI Pharmaceuticals raises FY25 adj. EPS view to $7.37-$7.64 from $6.98-$7.35
Premium
The Fly
ANI Pharmaceuticals raises FY25 adj. EPS view to $7.37-$7.64 from $6.98-$7.35
6M ago
ANIP
ANI Pharmaceuticals reports Q3 adjusted EPS $2.04, consensus $1.77
Premium
The Fly
ANI Pharmaceuticals reports Q3 adjusted EPS $2.04, consensus $1.77
6M ago
ANIP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >